Primary Sclerosing Cholangitis in Children | MicrobiomeTrials← Back to trialsNCT04181138
Primary Sclerosing Cholangitis in Children
RecruitingOBSERVATIONAL
Trial Details
Start: 2021-12-30Est. Completion: 2029-05-31
Enrollment target: 1,000 participants Locations- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Ann & Robert H Lurie Children's Hospital, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Cincinnati Children's Hospital Medical, Cincinnati, Ohio, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Texas Children's Hospital (Baylor College of Medicine), Houston, Texas, United States
- The University of Utah, Salt Lake City, Utah, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- The Hospital for Sick Children, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Primary Sclerosing Cholangitis
This study will evaluate the effects of elafibranor (the study drug) in participants with Primary Sclerosing Cholangitis…
Lancaster, United StatesEst. completion Sep 23, 2031
Primary Sclerosing Cholangitis (PSC)
In patients with PSC, endoscopic therapy of strictures aims to improve cholestasis by relieving the biliary obstruction …
London, United KingdomEst. completion Apr 1, 2027
Contact